1. P993: SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS. (23rd June 2022) Authors: Mancini, M.; Monaldi, C.; De Santis, S.; Papayannidis, C.; Rondoni, M.; Sartor, C.; Bruno, S.; Curti, A.; Zanotti, R.; Bonifacio, M.; Scaffidi, L.; Pagano, L.; Criscuolo, M.; Ciceri, F.; Elena, C.; Tosi, P.; Valent, P.; Cavo, M.; Soverini, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS. (23rd June 2022) Authors: Mancini, M.; De Santis, S.; Monaldi, C.; Bruno, S.; Castagnetti, F.; Gugliotta, G.; Iurlo, A.; Cerrano, M.; Galimberti, S.; Balducci, S.; Stagno, F.; Rosti, G.; Cavo, M.; Soverini, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗